期刊文献+

不同免疫分析系统测定血清心肌标志物的比对分析和偏倚评估 被引量:2

Comparative analysis and bias assessment of serum cardiac markers between different immunoassay systems
原文传递
导出
摘要 目的:探讨贝克曼DXI800化学发光免疫分析仪和梅里埃VIDAS荧光酶标免疫分析仪对肌钙蛋白I(TNI)、肌红蛋白(MYO)测定结果的可比性,为检验结果互认和临床实验室认可提供依据。方法:以贝克曼DXI800免疫分析仪为参考方法(X),梅里埃VIDAS免疫分析仪为试验方法(Y),用不同浓度的患者新鲜血清分别进行TNI、MYO的检测,计算两个分析系统测定结果的相关系数(r)及直线回归方程,计算TNI、MYO在医学决定水平处的预期误差。结果:两台仪器测定的TNI、MYO结果的相关系数均>0.975,偏倚均在临床允许误差范围内。结论:当使用两种以上检测系统检测同一项目时,应定期进行方法比对和偏倚评估,确保测定结果的可比性。本实验室的两台免疫分析仪测定TNI、MYO的结果具有较好的可比性。 Objective:To investigate the comparability between Beckman DXI800 immunoassay system and Bi- omerieux VIDAS inmmnoassay analyzer in determining troponin I (TNI) and myoglobin (MYO), and provide basis for mutual recognition of determination results and clinical laboratory accreditation. Methods : Beckman DXI800 im- mune system as the reference method ( X), the bioMerieux VIDAS immune analyzer as test method ( Y), the fresh serum from patients with different coneentrations was collected for detection of TNI and MYO. The correlation coeffi- cient (r) and the linear regression equation of TNI and MYO tested by the two analysis system were calculated for their expected error at medical decisions. Results : The correlation coefficients of TNI and MYO measured by the two instruments were 〉 0. 975, and bias were both in clinical permissible range. Conclusion: When using two or more detection systems to analyze the same project, method comparison and bias estimation can ensure the comparability of measurement results. The two immunoassay analyzers in this paper have good comparability to detect the concen- trations of TNI and MYO.
出处 《中国卫生检验杂志》 北大核心 2013年第2期403-405,共3页 Chinese Journal of Health Laboratory Technology
关键词 DXI800化学发光免疫分析仪 VIDAS荧光酶标免疫分析仪 比对分析 肌钙蛋白I 肌红蛋白 DXI800 chemiluminescence immunoassay system VIDAS enzyme - linked fluorescent immunoassayanalyzer Comparative analysis Troponin I Myoglobin
  • 相关文献

参考文献6

二级参考文献15

共引文献105

同被引文献12

  • 1朱文元,廖昆灵,刘芹.不同凝血分析仪检测纤维蛋白原结果的一致性评价[J].检验医学与临床,2012,9(4):479.
  • 2National Committee for Clinical Laboratory Standards.Method comparison and bias estimation using patient sampies[S].Aprovcd Guideline EP9-A2. Pennsylvania.N CCLS, 2002.
  • 3中华人民共和国卫生部.医疗机构I临床实验室管理办法[M].北京:卫生部,2006.
  • 4中国人民共和国卫生部医政司,编.全国临床检验操作规程(M)东南大学出版社, 2006
  • 5Annapoorna S Kini,Paul Lee,Jonathan D Marmur,Ajay Agarwal,Mary E Duffy,Michael C Kim,Samin K Sharma.??Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality(J)The American Journal of Cardiology . 2004 (1)
  • 6Panteghini Mauro,Pagani Franca.AACC creatine kinase MB (CK-MB) standardization material used as manufacturer’s working calibrator is unable to harmonize CK-MB results between two commercial immunoassays. Clinical Chemistry . 2004
  • 7林向阳,王忠永,周武,陶志华,陈晓东,杨建荣,温秀姝,袁谦,张文辉.不同检测系统甲胎蛋白测定结果的可比性及偏倚评估研究[J].中华检验医学杂志,2008,31(8):908-909. 被引量:13
  • 8涂少华,沈江帆,陶嵘,方云华,朱敏,杨琦,刘冲.联合检测血清AFP、CEA、CA19-9和CA72-4对消化道恶性肿瘤的筛查价值[J].标记免疫分析与临床,2008,15(4):245-247. 被引量:15
  • 9朱爱萍,吕秀英,郭书云.不同稀释介质对15个生化项目测定的影响[J].国际检验医学杂志,2009,30(3):214-216. 被引量:7
  • 10汪翼.肌酸激酶升高的临床意义与特发性高肌酸激酶血症[J].中国实用儿科杂志,2009,24(6):494-496. 被引量:33

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部